Self-Expanding Stents for Recanalization of Acute Cerebrovascular Occlusions

References

1. ↵
   Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–11

   CrossRefPubMedWeb of Science
2. ↵
   Gobin YP, Starkman S, Duckwiler GR, et al. MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke 2004;35:2848–54

   Abstract/FREE Full Text
3. ↵
   Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432–38

   Abstract/FREE Full Text
4. ↵
   Eckert B, Koch C, Thomalla G, et al. Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST): results of a multicenter study. Stroke 2005;36:1160–65

   Abstract/FREE Full Text
5. ↵
   Gupta R, Vora NA, Horowitz MB, et al. Multimodal reperfusion therapy for acute ischemic stroke: factors predicting vessel recanalization. Stroke 2006;37:986–90

   Abstract/FREE Full Text
6. Gupta R, Jovin TG, Tayal A, et al. Urgent stenting of the M2 (superior) division of the middle cerebral artery after systemic thrombolysis in acute stroke. AJNR Am J Neuroradiol 2006;27:521–23

   Abstract/FREE Full Text
7. ↵
   Levy EI, Ecker RD, Horowitz MB, et al. Stent-assisted intracranial recanalization for acute stroke: early results. Neurosurgery 2006;58:458–63

   CrossRefPubMedWeb of Science
8. Levy EI, Ecker RD, Hanel RA, et al. Acute M2 bifurcation stenting for cerebral infarction: lessons learned from the heart. Technical case report. Neurosurgery 2006;58:E588

   PubMed
9. ↵
   Qureshi AI, Siddiqui AM, Kim SH, et al. Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2004;25:322–28

   Abstract/FREE Full Text
10. ↵
    Summary of Safety and Probable Benefit: Wingspan Stent System with Gateway PTA Balloon Catheter. Available at: http://www.fda.gov/cdrh/pdf5/h050001b.pdf. Accessed February 27,2006 .
11. ↵
    Henkes H, Miloslavski E, Lowens S, et al. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology 2005;47:222–28

    CrossRefPubMedWeb of Science
12. ↵
    Sauvageau E, Levy EI. Self-expanding stent-assisted middle cerebral artery recanalization: technical note. Neuroradiology 2006;48:405–08

    CrossRefPubMedWeb of Science
13. ↵
    Levy EI, Sauvageau E, Hanel RA, et al. Self-expanding versus balloon-mounted stent-assisted recanalization following embolic occlusion in the canine model: technical feasibility study. AJNR Am J Neuroradiol 2006;27:2069–72

    Abstract/FREE Full Text
14. ↵
    Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med 1994;330:956–61

    CrossRefPubMedWeb of Science
15. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators. N Engl J Med 1997;336:1689–96

    CrossRefPubMedWeb of Science
16. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study [published erratum appears in Lancet 1997; 350: 744]. Lancet 1997;349:1429–35

    CrossRefPubMedWeb of Science
17. ESPRIT Investigators. Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial [published erratum appears in Lancet 2001; 357: 1370]. Lancet 2000;356:2037–44

    CrossRefPubMedWeb of Science
18. Steinhubl SR, Talley JD, Braden GA, et al. Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study. Circulation 2001;103:2572–78

    Abstract/FREE Full Text
19. ↵
    Walter DH, Schachinger V, Elsner M, et al. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet 1997;350:1217–19

    CrossRefPubMedWeb of Science
20. ↵
    The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 1985;312:932–36

    PubMed
21. Higashida R, Furlan A, Roberts H, et al. Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. J Vasc Interv Radiol 2003;14:S493–S494

    CrossRefPubMed
22. Higashida RT, Furlan AJ, Roberts H, et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:e109–137

    Abstract/FREE Full Text
23. ↵
    Sheehan FH, Braunwald E, Canner P, et al. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. Circulation 1987;75:817–29

    Abstract/FREE Full Text
24. ↵
    Lincoff AM, Topol EJ. Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation 1993;88:1361–74

    Abstract/FREE Full Text
25. ↵
    Ringer AJ, Qureshi AI, Fessler RD, et al. Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke. Neurosurgery 2001;48:1282–90

    CrossRefPubMedWeb of Science
26. ↵
    Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 2006;27:1177–82

    Abstract/FREE Full Text
27. ↵
    Levy EI, Hanel RA, Howington JU, et al. Sirolimus-eluting stents in the canine cerebral vasculature: a prospective, randomized, blinded assessment of safety and vessel response. J Neurosurg 2004;100:688–94

    PubMedWeb of Science
28. ↵
    Levy EI, Hanel RA, Tio FO, et al. Safety and pharmacokinetics of sirolimus-eluting stents in the canine cerebral vasculature: 180-day assessment. Neurosurgery 2006;59:925–33; discussion 933–4

    CrossRefPubMedWeb of Science
29. ↵
    Smith S. for the Multi-MERCI Investigators. Results of the Multi-MERCI trial (abstract P503). Stroke 2006;37:711–12
30. ↵
    Fiorella D, Albuquerque FC, Deshmukh VR, et al. In-stent stenosis as a delayed complication of Neuroform stent-supported coil embolization of an incidental carotid terminus aneurysm. AJNR Am J Neuroradiol 2004;25:1764–67

    Abstract/FREE Full Text